Q93-56320-74776
2 vaccinations
2 coded responses
10 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 405 / KY
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-22
Dose 1 — Pfizer-BioNTech
-
2021-03-15
Registered in v-safe
-
2021-03-15
Dose 2 — Pfizer-BioNTech
- 2021-03-15
-
2021-03-16
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Syncope — Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to workFree text: faint and dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-17
- 2021-03-18
-
2021-03-19
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Tremor — Feeling: Fair · HeadacheFree text: hands shaking, light headed feelingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-29
- 2021-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-22 | Pfizer-BioNTech | |
| 2 | 2021-03-15 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): faint and dizziness
Systemic reaction (other): hands shaking, light headed feeling
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Syncope | ✓ | ✓ | ✓ |
| SRO | Tremor | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release